-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Windtree Therapeutics Inc /De/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Windtree Therapeutics Inc /De/ Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.74M, a 1.09% decline year-over-year.
- Windtree Therapeutics Inc /De/ Operating Income (Loss) for the twelve months ending September 30, 2024 was -$25.6M, a 3.38% increase year-over-year.
- Windtree Therapeutics Inc /De/ annual Operating Income (Loss) for 2023 was -$20.6M, a 50.2% increase from 2022.
- Windtree Therapeutics Inc /De/ annual Operating Income (Loss) for 2022 was -$41.3M, a 46.5% increase from 2021.
- Windtree Therapeutics Inc /De/ annual Operating Income (Loss) for 2021 was -$77.3M, a 155% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)